Cargando…

An Investigation of the Risk Factors Associated With Anti-Tuberculosis Drug-Induced Liver Injury or Abnormal Liver Functioning in 757 Patients With Pulmonary Tuberculosis

Objectives: To identify the risk factors associated with anti-tuberculosis drug-induced liver injury (AT-DILI) or abnormal living functioning from 757 patients with pulmonary tuberculosis (TB) registered at Nanshan Center for Chronic Disease Control (Nanshan CCDC), Shenzhen, Guangdong Province, Chin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Tao, Fan, Yuzheng, Dong, Xiao-Li, Guo, Xujun, Wong, Ka Hing, Wong, Wing-tak, He, Daihai, Liu, Shengyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606396/ https://www.ncbi.nlm.nih.gov/pubmed/34819852 http://dx.doi.org/10.3389/fphar.2021.708522

Ejemplares similares

Predicting Antituberculosis Drug–Induced Liver Injury Using an Interpretable Machine Learning Method: Model Development and Validation Study
por: Zhong, Tao, et al.
Publicado: (2021)

Correction: Predicting Antituberculosis Drug–Induced Liver Injury Using an Interpretable Machine Learning Method: Model Development and Validation Study
por: Zhong, Tao, et al.
Publicado: (2021)

757. Community Prevalence of Bacteriologically Confirmed Pulmonary Tuberculosis: A 7-Year Retrospective Study
por: Sethuraman, Nandini, et al.
Publicado: (2018)

Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
por: Wang, Ming-Gui, et al.
Publicado: (2022)

Vacant Seat on the 7.57
por: Payne, John
Publicado: (1970)

HLA-B(*)57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians
por: Petros, Zelalem, et al.
Publicado: (2017)

A nomogram model to predict the risk of drug-induced liver injury in patients receiving anti-tuberculosis treatment
por: Ji, Songjun, et al.
Publicado: (2023)

N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study
por: Cheng, Fang, et al.
Publicado: (2023)

Association of PI3K/AKT/mTOR pathway autophagy-related gene polymorphisms with pulmonary tuberculosis susceptibility in a Chinese population
por: He, Juan, et al.
Publicado: (2023)

Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury
por: Huang, Deliang, et al.
Publicado: (2023)

A Comprehensive App That Improves Tuberculosis Treatment Management Through Video-Observed Therapy: Usability Study
por: Guo, Xujun, et al.
Publicado: (2020)

Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China
por: Sichen, Li, et al.
Publicado: (2023)

Xiao-Yao-San protects against anti-tuberculosis drug-induced liver injury by regulating Grsf1 in the mitochondrial oxidative stress pathway
por: Bai, Zijun, et al.
Publicado: (2022)

Hematological and liver toxicity of anti-tuberculosis drugs
por: Mirlohi, Maryam-Sadat, et al.
Publicado: (2016)

Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis
por: Wang, Xiaofeng, et al.
Publicado: (2020)

Asthma Therapies on Pulmonary Tuberculosis Pneumonia in Predominant Bronchiectasis–Asthma Combination
por: Yeh, Jun-Jun, et al.
Publicado: (2022)

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis
por: Abulfathi, Ahmed A., et al.
Publicado: (2021)

Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis
por: Stemkens, Ralf, et al.
Publicado: (2023)

Complex Germline K757N Mutation in Non-Small-Cell Lung Cancer: A Case Report
por: Wong, Boaz, et al.
Publicado: (2022)

Postprimary Tuberculosis and Macrophage Necrosis: Is There a Big ConNECtion?
por: Wong, Ka-Wing, et al.
Publicado: (2016)

Polymorphisms of the BCL2 gene associated with susceptibility to tuberculosis
por: He, Juan, et al.
Publicado: (2022)

Systems Pharmacology Study of the Anti-Liver Injury Mechanism of Citri Reticulatae Pericarpium
por: Wu, Jianxiong, et al.
Publicado: (2021)

Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan
por: Cheng, Kao-Chi, et al.
Publicado: (2017)

Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis
por: Ernest, Jacqueline P., et al.
Publicado: (2021)

Clofazimine for the treatment of tuberculosis
por: Stadler, Jacob A. M., et al.
Publicado: (2023)

Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis
por: Rajput, Amarjitsing, et al.
Publicado: (2021)

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies
por: Alffenaar, Jan-Willem C., et al.
Publicado: (2022)

A Quantitative Systems Pharmacology Model of Liver Lipid Metabolism for Investigation of Non-Alcoholic Fatty Liver Disease
por: Rieger, Theodore R., et al.
Publicado: (2022)

Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver
por: Rivera, Patricia, et al.
Publicado: (2017)

Effectiveness of Prophylactic Use of Hepatoprotectants for Tuberculosis Drug-Induced Liver Injury: A Population-Based Cohort Analysis Involving 6,743 Chinese Patients
por: Chen, Qin, et al.
Publicado: (2022)

Association between Health-Related Quality of Life and Medication Adherence in Pulmonary Tuberculosis in South Africa
por: Kastien-Hilka, Tanja, et al.
Publicado: (2017)

Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis
por: Mallikaarjun, Suresh, et al.
Publicado: (2020)

Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China
por: Zou, Jin, et al.
Publicado: (2022)

Ganoderma lucidum: Current advancements of characteristic components and experimental progress in anti-liver fibrosis
por: Peng, Haoyuan, et al.
Publicado: (2023)

Critical role for NLRP3 in necrotic death triggered by Mycobacterium tuberculosis
por: Wong, Ka-Wing, et al.
Publicado: (2011)

HMGB1/RAGE Signaling and Pro-Inflammatory Cytokine Responses in Non-HIV Adults with Active Pulmonary Tuberculosis
por: Lui, Grace, et al.
Publicado: (2016)

Alginate-Capped Silver Nanoparticles as a Potent Anti-mycobacterial Agent Against Mycobacterium tuberculosis
por: Chen, Cheng-Cheung, et al.
Publicado: (2021)

Population-Based Case-Control Study Assessing the Association between Statins Use and Pulmonary Tuberculosis in Taiwan
por: Liao, Kuan-Fu, et al.
Publicado: (2017)

Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China
por: Shang, Penghui, et al.
Publicado: (2011)

Primary Solitary Tuberculosis of the Liver
por: Emre, Ali, et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_lmooitlpki0r3kboskmb9gvhuq